DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/012af7/hyperthyroidism_gl) has announced the addition of GlobalData 's new report "Hyperthyroidism Global Clinical Trials Review, H2, 2011" to their offering.
GlobalData's clinical trial report, Hyperthyroidism Global Clinical Trials Review, H2, 2011" provides data on the Hyperthyroidism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperthyroidism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperthyroidism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Key Topics Covered:
- Introduction
- Hyperthyroidism
- Report Guidance
- Clinical Trials by Region
- Clinical Trials by Country
- Top Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Clinical Trials by BRIC Nations
- Clinical Trials by G7 Nations
- Clinical Trials in G7 Nations by Trial Status
- Clinical Trials by E7 Nations
- Clinical Trials in E7 Nations by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Subjects Recruited Over a Period of Time
- Prominent Sponsors
- Prominent Drug Comparison
- Clinical Trial Profiles
- Clinical Trial Overview of Top Universities / Institutes / Hospitals
- Five Key Clinical Profiles
- Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
For more information visit http://www.researchandmarkets.com/research/012af7/hyperthyroidism_gl